Multicenter RCT for BIliary Brushing: RX Cytology, BOSTON vs. Infinity®, US Endoscopy (BIB)

Multicenter RCT Comparing Two Brushes of Different Diameters for Biliary Stenosis: RX Cytology Brush, BOSTON vs. Infinity® Brush, US Endoscopy. BIB Study (BIliary Brushing)

The aim of this prospective national multicenter randomized study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush® The main objective is the comparison of the rates of positive diagnosis of biliary brushing in cases of adenocarcinoma stenosis The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years

Study Overview

• Status: Completed
• Conditions: Biliary Stricture; Jaundice, Obstructive
• Intervention / Treatment: Device: Biliary brushing with the RX Cytology brush, Boston Scientific; Device: Biliary brushing with the Infinity® brush, US Endoscopy

Detailed Description

The aim of this study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush®

OBJECTIVES

• Main objective: Comparison of the rates of positive diagnosis of biliary brushing in cases of adenocarcinoma stenosis

• Secondary objective (s):

  • Comparison of the quantification of the cellular material obtained (acellular, weak, or abundant), and the presence of cellular cupboards unhooked by the brush
  • Comparison of the 2 brushes false negative rates, and negative predictive value for the diagnosis of adenocarcinoma
  • Evaluation of the variation in the profitability of brushing and other sampling techniques (intra-biliary biopsies, puncture, aspiration of bile) according to the presence of a tumor mass syndrome of more than 1 cm.
  • Evaluation of the variation in the profitability of brushing and other sampling techniques (intra-biliary biopsies, puncture, aspiration of bile) according to the site of the stenosis (distal vs proximal BPV: common bile duct or intrahepatic duct), with the cost effectiveness
  • Technical failure rate of brushing and other samples (intra-biliary biopsies, bile aspiration)

This study concerns adult subjects with stenosis of the main bile duct (common bile duct or common hepatic duct).

ENDOSCOPIC PROCEDURE

• Deep catheterization of the biliary duct (whatever the access technique: by the papilla or by precut) and cross stenosis by the guide wire, then biliary dilation (6 to 8mm)
• Randomization if the inclusion criteria are met

• Biliary brushing successively with the 2 brushes in the order designated by randomization:

  • Performing a dozen back and forth movements in the stenosis
  • Aspiration, if possible of bile by the catheter of the brush for cytological analysis
  • The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2
• In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)

All possible sampling methods will also be taken to obtain the anatomopathological diagnosis: intra-biliary biopsies with adult or pediatric forceps, wire-guided or not, biopsy samples guided by choledochoscopy, puncture under endo-ultrasonography, bile aspiration after release of the biliary stent, according to the physician's habits.

EFFECTIVE The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years

• Study Type: Interventional
• Enrollment (Actual): 51
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Charenton-le-Pont, France, F-94220
    • Clinique Paris Bercy

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 88 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patient admitted to one of the ERCP investigation centers with brushing and drainage for VBP stenosis (proximal or distal) during the study period
• Patient whose age is greater than or equal to 18 years and less than 90 years
• Patient ASA 1, ASA 2, ASA 3
• Lack of participation in another clinical study
• Signed informed consent

Exclusion Criteria:

• Patients admitted for ERCP for jaundice by lithiasic obstruction
• Patient under 18 or over 90
• Patient ASA 4, ASA 5
• Pregnant woman
• Patient (s) with coagulation abnormalities preventing puncture: TP <50%, Platelets <50,000 / mm3, effective anti-coagulation in progress, clopidogrel in progress
• Surgical setup (Billroth II, Roux en Y) preventing endoscopic access to the papilla
• Patient unable to give personal consent
• Lack of signed informed consent

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Group A: RX Cytology brush, Boston Scientific FIRST; A first biliary brushing will be carried out during ERCP using a standard brush RX Cytology Brush, Boston Scientific, then a second brushing will be carried out using a brush INFINITY®, US Endoscopy	Device: Biliary brushing with the RX Cytology brush, Boston Scientific; Biliary brushing during ERCP: Performing a dozen back and forth movements in the stenosis; Bile aspiration if possible, by the catheter of the brush for cytological analysis; The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back); Device: Biliary brushing with the Infinity® brush, US Endoscopy; Biliary brushing during ERCP: Performing a dozen back and forth movements in the stenosis; Bile aspiration if possible, by the catheter of the brush for cytological analysis; The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)
Active Comparator: Group B: Infinity®, US Endoscopy FIRST; A first biliary brushing will be carried out during ERCP using an INFINITY® brush, US Endoscopy then a second brushing will be carried out using standard RX Cytology Brush, Boston Scientific	Device: Biliary brushing with the RX Cytology brush, Boston Scientific; Biliary brushing during ERCP: Performing a dozen back and forth movements in the stenosis; Bile aspiration if possible, by the catheter of the brush for cytological analysis; The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back); Device: Biliary brushing with the Infinity® brush, US Endoscopy; Biliary brushing during ERCP: Performing a dozen back and forth movements in the stenosis; Bile aspiration if possible, by the catheter of the brush for cytological analysis; The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sensibility for adenocarcinoma	Rate of positive diagnosis of biliary brushing in case of cholangiocarcinoma stenosis	8 days to 1 year (if negative)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sample abundance	Quantification of the cellular material obtained (acellular, weak, or abundant), presence of cellular cupboards unhooked by the brush or average number of cells per field	8 days
False negative	Negative brushing for a final diagnosis of cholangiocarcinoma	1 year
Predictive Negative Value	probability that patients with a negative brushing truly don't have cholangiocarcinoma	1 year
Feasibility of the 2 brushes: Analog visual scale	Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)	1 day
Feasibility of the intra-biliary biopsies: Analog visual scale	Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)	1 day
Feasibility of bile aspiration: Analog visual scale	Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)	1 day
Feasibility of stenosis puncture under ultrasonography: Analog visual scale	Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)	1 day

Collaborators and Investigators

• Sponsor: Société Française d'Endoscopie Digestive

Study record dates

Study Major Dates

• Study Start (Actual): July 1, 2020
• Primary Completion (Actual): March 1, 2022
• Study Completion (Actual): March 1, 2022

Study Registration Dates

• First Submitted: January 25, 2020
• First Submitted That Met QC Criteria: January 30, 2020
• First Posted (Actual): January 31, 2020

Study Record Updates

• Last Update Posted (Actual): June 21, 2022
• Last Update Submitted That Met QC Criteria: June 17, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Skin Manifestations; Hyperbilirubinemia; Jaundice; Jaundice, Obstructive
• Other Study ID Numbers: BIB study

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No